Cirrhosis Clinical Trials 2022

Browse 45 Cirrhosis Medical Studies Across 204 Cities

8 Phase 3 Trial · 713 Cirrhosis Clinics

Reviewed by Michael Gill, B. Sc.
25 Cirrhosis Clinical Trials Near Me
Portland, OR
Toronto, Canada
Indianapolis, IN
San Francisco, CA
More Trial Locations
An interactive map to display trial locations for Oregon Health and Science University, Toronto General Hospital, Indiana University Hospital, University of California, San Francisco Liver Clinic, and 270 more locations.
Most Popular References for Cirrhosis Clinical Trials
Frequency
Citation
Top Hospitals for Cirrhosis Clinical Trials
Top Treatments for Cirrhosis Clinical Trials
Treatment Name
Active Cirrhosis Clinical Trials
All Time Trials for Cirrhosis
First Recorded Cirrhosis Trial
Trials
Transjugular Intrahepatic Portosystemic Shunt (TIPS) creation
1
1
2022
Hepatology Home Hospital
1
1
2022
Top Cities for Cirrhosis Clinical Trials
City
Active Cirrhosis Clinical Trials
Top Active Site for Cirrhosis Clinical Trials
Trial List
Dallas, Texas
24
University of Texas Southwestern Medical Center
Richmond, Virginia
21
Hunter Holmes McGuire VA Medical Center
Houston, Texas
21
Baylor College of Medicine - Advanced Liver Therapies
How many cirrhosis clinical trials are open to youth and / or seniors?
Most Recent Cirrhosis Clinical Trials
Phase 3 Cirrhosis Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
8/26/2022
Phase 3
11/10/2021
Phase 2 & 3
Senior Friendly Cirrhosis Clinical Trials
Recently Completed Studies with FDA Approved Treatments for Cirrhosis
Treatment
Year
Mechanism of Action
Sponsor
Active Cirrhosis Clinical Trials
Proglumide
2021
Proglumide
Georgetown University
0
BMS-986036
2018
Pegbelfermin
Bristol-Myers Squibb
0

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 12th, 2021

Last Reviewed: August 22nd, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.